Acceptability and Feasibility of a Pharmacist-Led Human Immunodeficiency Virus Pre-Exposure Prophylaxis Program in the Midwestern United States

BACKGROUND: Human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) substantially reduces the risk of HIV acquisition, yet significant barriers exist to its prescription and use. Incorporating pharmacists in the PrEP care process may help increase access to PrEP services. METHODS: Our pha...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Open Forum Infect Dis
Autors principals: Havens, Joshua P, Scarsi, Kimberly K, Sayles, Harlan, Klepser, Donald G, Swindells, Susan, Bares, Sara H
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Major Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6765348/
https://ncbi.nlm.nih.gov/pubmed/31412131
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz365
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars